Asthma and COPD

1. Definitions, Epidemiology and Genetics of Asthma and COPD<br>2. Epidemiology<br>3. Natural History<br>4. Genetics of Asthma and COPD<br>5. Pulmonary Physiology<br>6. Airway Pathology <br>7. Airway Remodeling<br>8. Animal Models<br>9. Mast Cells and Basophils<br>10. Dentritic Cells<br>11. Macrophages<br>12. Eosinophils<br>13. Lymphocytes<br>14. Neutrophils<br>15. Fibroblasts<br>16. Epithelial Cells<br>17. Mucus and Mucin-Secreting Cells<br>18. Airway Smooth Muscle<br>19. Tracheobronchial Circulation<br>20. Pulmonary Vessels<br>21. Adhesion Molecules <br>22. Extracellular Matrix<br>23. Prostanoids<br>24. Leukotrienes and Lipoxins<br>25. Reactive Oxygen Species <br>26. Chemokines<br>27. Cytokines<br>28. Matrix Degrading Proteinases<br>29. Growth Factors, <br>30. Nitric Oxide<br>31. Transcription Factors<br>32. Neural and Humoral Control<br>33. Pathophysiology of Asthma<br>34. Pathogenesis of COPD<br>35. Allergens<br>36. Occupational Agents<br>37. Infections<br>38. Exercise as a Stimulus<br>39. Atmospheric Pollutants<br>40. Drugs<br>41. Diagnosis<br>42. Non-invasive Assessment of Airway Inflammation<br>43. Imaging<br>44. Systemic Manifestations<br>45. Cardiovascular Effects<br>46. Allergen Avoidance<br>47. Smoking Cessation<br>48. â2-adrenoceptor Agonists<br>49. Anticholinergic Bronchodilators<br>50. Theophylline<br>51. Corticosteroids<br>52. Mediator Antagonists<br>53. Antibiotics<br>54. Long-term Oxygen Therapy<br>55. Immunomodulators<br>56. Pulmonary Vasodilators<br>57. Ventilator Support<br>58. Pulmonary Rehabilitation<br>59. Surgery and Other Mechanical Interventions<br>60. Other Therapies<br>61. Future Therapies<br>62. Health Economics<br>63. Management of Chronic Asthma in Adults<br>64. Asthma Exacerbations<br>65. Childhood Asthma<br>66. Treatment for Stable COPD<br>67. Acute Exacerbations of COPD<br>68. Education and Self-Management